AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the ...

When it comes to constantly adapting to the progression of her husband's ALS, columnist Kristin Neva is both an "old-timer" and a student.

Yentli Soto Albrecht, who is a genetic carrier of ALS, is working on research at Penn that could one day prove life-saving.

Asking for help or giving instructions can feel intimidating, but being pushy helps ensure patients' well-being, says columnist.

"Watching my mom die of ALS was one of the most awful things I’ve gone through. I don’t want my children to see me suffer ...

As Congress debates renewing the Act for ALS, it must prepare for the coming era of precision ALS medicine by prioritizing ...

Researchers have uncovered a surprising connection between gut bacteria and the development of ALS and frontotemporal dementia. Their work suggests that certain microbes produce inflammatory sugars ...

In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people ...

A protein tied to ALS and dementia may have a much bigger role in disease than scientists realized. Researchers found that ...

Eric Dane’s death has sparked conversations about the speed and severity of ALS. Also known as Lou Gehrig’s disease, the progressive illness — officially called amyotrophic lateral sclerosis — is ...

Eric Dane is sharing everything about his ALS battle — including the emotional toll that the devastating diagnosis has taken on him. The “Euphoria” actor, 53, gave the latest update on his health ...

Eric Dane, the actor best known for his role as Dr. Mark Sloan on the hit medical series "Grey's Anatomy," has died at the age of 53, his family announced Thursday. In April 2025, Dane announced he ...